Back
Diebold Nixdorf, Inc. Vs. Olema Pharmaceuticals, Inc. Industry Stock Comparison
Buy
76
DBD
Diebold Nixdorf, Inc.
Last Price:
$67.11
Seasonality Move:
11.65%
Buy
60
OLMA
Olema Pharmaceuticals, Inc.
Last Price:
$30.66
Seasonality Move:
-6.94%
Buy
76
Diebold Nixdorf, Inc. (DBD)
is a Buy
Is Diebold Nixdorf, Inc. a Buy, Sell or Hold?
-
The current Diebold Nixdorf, Inc. [DBD] share price is $65.60. The Score for DBD is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
-
DBD is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
60
Olema Pharmaceuticals, Inc. (OLMA)
is a Buy
Is Olema Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Olema Pharmaceuticals, Inc. [OLMA] share price is $26.58. The Score for OLMA is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
OLMA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DBD Stock Price Chart
What is Diebold Nixdorf, Inc.'s stock price today?
-
The Diebold Nixdorf, Inc. share price today is $65.60Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DBD is experiencing selling pressure, which indicates risk of future bearish movement.
OLMA Stock Price Chart
What is Olema Pharmaceuticals, Inc.'s stock price today?
-
The Olema Pharmaceuticals, Inc. share price today is $26.58Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and OLMA is experiencing slight selling pressure.
DBD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.32 | Buy |
| Relative Strength Index (14 RSI): | 59.37 | Buy |
| Chaikin Money Flow: | -339468 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (61.65 - 66.13) | Buy |
| Bollinger Bands (100): | (56.97 - 63.13) | Buy |
OLMA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.6 | Buy |
| Relative Strength Index (14 RSI): | 74.25 | Buy |
| Chaikin Money Flow: | -585363 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.87 - 27.45) | Buy |
| Bollinger Bands (100): | (3.4 - 17.02) | Buy |
DBD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 65.35 | Buy |
| 20-day SMA: | 64.13 | Buy |
| 50-day SMA: | 60.72 | Buy |
| 200-day SMA: | 53.81 | Buy |
| 8-day EMA: | 65.13 | Buy |
| 20-day EMA: | 63.97 | Buy |
| 50-day EMA: | 61.85 | Buy |
| 200-day EMA: | 55.23 | Buy |
OLMA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.51 | Sell |
| 20-day SMA: | 21.26 | Buy |
| 50-day SMA: | 14.13 | Buy |
| 200-day SMA: | 7.33 | Buy |
| 8-day EMA: | 26.63 | Sell |
| 20-day EMA: | 22.44 | Buy |
| 50-day EMA: | 16.3 | Buy |
| 200-day EMA: | 9.75 | Buy |
Diebold Nixdorf, Inc. Earnings Growth & DBD Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.47 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.40 per share, and an increase next year of $0.89 per share.
Olema Pharmaceuticals, Inc. Earnings Growth & OLMA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.60 per share, and a decrease next year of $0.48 per share.
Diebold Nixdorf, Inc. Technical Analysis
| Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Olema Pharmaceuticals, Inc. Technical Analysis
| Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||